Exact Sciences
EXAS
#1704
Rank
C$13.91 B
Marketcap
$75.17
Share price
1.31%
Change (1 day)
-15.78%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of September 2024 : C$4.48 Billion

According to Exact Sciences's latest financial reports the company has C$4.48 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$4.17 B1.03%
2022-12-31$C$4.12 B-4.35%
2021-12-31$C$4.31 B51.46%
2020-12-31$C$2.85 B-4.61%
2019-12-31$C$2.98 B222.17%
2018-12-31$C$0.92 B41.77%
2017-12-31$C$0.65 B45.21%
2016-12-31$C$0.45 B-0.62%
2015-12-31$C$0.45 B35.2%
2014-12-31$C$0.33 B132.82%
2013-12-31$C$0.14 B46.92%
2012-12-31$C$98.04 M15.44%
2011-12-31$C$84.93 M6.53%
2010-12-31$C$79.72 M1143.31%
2009-12-31$C$6.41 M-316.75%
2008-12-31$-C$2.96 Million-147.16%
2007-12-31$C$6.27 M-63.98%
2006-12-31$C$17.41 M-39.24%
2005-12-31$C$28.66 M-37.17%
2004-12-31$C$45.62 M187.61%
2003-12-31$C$15.86 M-73.81%
2002-12-31$C$60.56 M-35.52%
2001-12-31$C$93.93 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$1.03 B-76.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.64 B-63.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.4 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
C$109.39 B 2,337.36%๐Ÿ‡ซ๐Ÿ‡ท France